Duke-Robert J. Margolis, MD, Institute for Health Policy

04/15/2026

How can we transform health and improve health outcomes in the rural United States? Speakers will explore this issue during a session at the Duke-Margolis 2026 Health Policy Conference on May 13. Hear from these experts:

Rajaie Batniji, Waymark
Dan Brillman, Director of Medicaid and CHIP Services, and Deputy Administrator, Centers for Medicare & Medicaid Services (tentative)
Bruce Greenstein, Louisiana Department of Health
Meena Seshamani, Maryland Department of Health

Join us at the Westin Washington Downtown DC for this conversation and a wide range of other timely health policy topics! The conference will be followed by a free networking reception, where attendees can meet with their peers and discuss the issues further. Space is filling fast for in-person attendance! Register today: https://duke.is/HPC2026

04/14/2026

Join us for a special Duke-Margolis Seminar featuring Anup Malani, Lee and Brena Freeman Professor at the University of Chicago Law School, currently on leave to serve as the Chief Economist, Centers for Medicare & Medicaid Services.

Enrollment in Affordable Care Act individual market plans with zero claims raises important questions about enrollee health status, coverage transitions to Medicaid, and the potential for improper enrollment. Using administrative and enrollment data, Anup will discuss the drivers of zero‑claim enrollment to distinguish between healthy non‑utilizers, individuals experiencing mid‑year coverage shifts, and cases that may reflect administrative or policy misalignment.

Learn more and register here: https://duke.is/m/9e8n

04/10/2026

Don't miss our 2026 Health Policy Conference, where speakers will explore some of the most pressing health policy challenges facing the United States. Join us as we reflect on progress and look ahead to new opportunities to improve health and health care for all: https://duke.is/HPC2026

04/09/2026

Our next event is just a few days away! Don't miss your chance to register for "Scaling Innovative Clinical Trial Approaches: Challenges, Progress, and Opportunities," where speakers will explore strategies to encourage broader adoption of innovative clinical trial approaches. Read the agenda and register here: https://duke.is/m/qy4t

04/03/2026

Check out the new draft agenda for our upcoming event, "Increasing Access to Nonprescription Drugs!" Speakers will explore opportunities to improve public health with nonprescription treatments, evidence generation to demonstrate safety and efficacy in the nonprescription setting, and innovation to enable increased access to nonprescription drugs. Read the draft agenda and register here: https://duke.is/p/4g3b

04/01/2026

As clinical AI tools are embedded in care delivery, new opportunities to improve patient care increase along with new patient safety risks. Duke-Margolis and Duke Health AI Evaluation & Governance have released a white paper that explores this issue in detail, highlighting recommendations for health systems to create effective AI risk management and patient safety event reporting. Read more here: https://duke.is/m/rrnn

03/25/2026

Registration closes soon! Join us on Monday for the third workshop in the RISE series, co-convened with the FDA Rare Disease Innovation Hub, where our expert speakers will explore the potential of data sharing to advance rare disease clinical trials and medical product development. Space is filling fast for in-person attendance, so be sure to secure your spot: https://duke.is/2/t6dr

03/18/2026

A new hybrid meeting has been announced! Join us on April 23 for this event, hosted under a cooperative agreement with the U.S. Food and Drug Administration, that will explore opportunities to increase access to nonprescription drugs. For more opportunities to network with your peers, we invite you to attend in-person at the National Press Club. Space is limited! Register today: https://duke.is/p/4g3b

03/17/2026

Hear the latest in clinical trial innovation at our upcoming hybrid workshop, co-convened with the U.S. Food and Drug Administration (FDA) CDER Center for Clinical Trial Innovation (C3TI). On April 14, we are gathering expert speakers to discuss C3TI activities as well as strategies to advance broader adoption of innovative approaches in the design and conduct of clinical trials. Learn more and register here: https://duke.is/m/qy4t

03/13/2026

Don't miss the 2026 Duke MBA Health Care Conference! The Duke Fuqua School of Business Health Care Club is hosting their annual conference on March 25 to discuss health care innovation. Dev Sangvai, Secretary of the North Carolina Department of Health and Human Services, is the keynote speaker at the event. Hear from our Senior Research Director, Marianne Hamilton Lopez, who will discuss cell and gene therapies, as well as Core Faculty member David Ridley as he moderates a panel discussion on emerging markets. Learn more and register here:

From Innovation to Impact: The Business of Transforming Healthcare 3.25.2026 Go to Duke MBA Health Care Club

03/11/2026

Speakers have been announced! Join us in just a few weeks for a hybrid workshop exploring how data sharing can advance rare disease therapy development. We're gathering a group of expert speakers at the National Press Club in Washington, DC, on March 30 to discuss this issue and share case examples of data sharing in practice, featuring different types of data. Read the draft agenda and register here: https://duke.is/2/t6dr

03/05/2026

In just a few weeks, we are co-hosting an event with the Duke Health AI Evaluation & Governance Program! Clinical AI tools are increasingly embedded in care delivery, creating new opportunities to improve outcomes but also new patient safety risks that require proactive risk management. Join us for a webinar on March 24 that will explore strategies to protect patients in the age of AI: https://duke.is/5/cg7u